The Indian clinical trials market is rapidly expanding, making it an attractive destination for global pharmaceutical companies. With a market size of over $1.5 billion and an annual growth rate exceeding 12%, India stands out due to its cost-effective solutions, high-quality research infrastructure, and a large, diverse patient population.
According to the Clinical Trials Registry - India (CTRI), there are over 3,000 registered investigator sites across the country. These sites are strategically distributed to leverage the diverse patient populations and regional expertise available throughout India.
This regional distribution ensures that clinical trials can access varied patient demographics and medical expertise, enhancing the generalizability and success rates of clinical studies.
Objective and Unbiased Assessment: Relying on a single CRO for site selection can lead to biased assessments due to potential conflicts of interest. Our independent consultancy provides an unbiased evaluation, ensuring that the selected sites are genuinely the best fit for your clinical trial requirements.
Comprehensive Site Evaluation: Our service includes a thorough evaluation of potential investigator sites, covering:
Regulatory and Compliance Assurance: Navigating the regulatory landscape in India can be complex. We ensure that all potential sites comply with local and international regulatory standards, including:
Enhanced Site Performance Metrics: Our independent evaluation focuses on site performance metrics, providing a clear picture of each site's capabilities:
